Pfizer Lines Up Trio Of US Biosimilar Launches

Bevacizumab, Rituximab And Trastuzumab Slated For US Entry

 
• By Aidan Fry
  
Toy_Cars
Pfizer expects within the next few months to bring three biosimilars to the US market • Source: Shutterstock

More from Biosimilars

More from Products